PH25728A - Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type - Google Patents

Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type

Info

Publication number
PH25728A
PH25728A PH37078A PH37078A PH25728A PH 25728 A PH25728 A PH 25728A PH 37078 A PH37078 A PH 37078A PH 37078 A PH37078 A PH 37078A PH 25728 A PH25728 A PH 25728A
Authority
PH
Philippines
Prior art keywords
antigestagen
trilostane
synthesis inhibitor
progesteron
combined use
Prior art date
Application number
PH37078A
Other languages
English (en)
Inventor
Walter Dr Elger
Sybille Dr Beir
Beate Kosub
Marrianne Fanrich
Of Dr Krzysztof Dr Chwalisz
Gordon Dr Oliver
Original Assignee
Schering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering filed Critical Schering
Publication of PH25728A publication Critical patent/PH25728A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH37078A 1987-06-16 1988-06-15 Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type PH25728A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720420 DE3720420A1 (de) 1987-06-16 1987-06-16 Progesteronsynthesehemmer und antigestagene zur geburtseinleitung oder fuer den schwangerschaftsabbruch

Publications (1)

Publication Number Publication Date
PH25728A true PH25728A (en) 1991-10-18

Family

ID=6329981

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37078A PH25728A (en) 1987-06-16 1988-06-15 Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type

Country Status (12)

Country Link
EP (1) EP0296097B1 (fr)
JP (1) JP2716461B2 (fr)
AT (1) ATE94391T1 (fr)
AU (1) AU611160B2 (fr)
CA (1) CA1318251C (fr)
DE (2) DE3720420A1 (fr)
DK (1) DK327288A (fr)
ES (1) ES2059556T3 (fr)
IE (1) IE63453B1 (fr)
IL (1) IL86731A (fr)
PH (1) PH25728A (fr)
ZA (1) ZA884315B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3522753B2 (ja) * 1992-09-25 2004-04-26 バーンズ，クライブ ビールラインにおける汚染物質の堆積防止
GB2345851B (en) * 2000-01-18 2004-05-26 Gavin Paul Vinson A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity

Also Published As

Publication number Publication date
EP0296097A2 (fr) 1988-12-21
JP2716461B2 (ja) 1998-02-18
DK327288A (da) 1988-12-17
EP0296097A3 (en) 1990-04-04
DE3884067D1 (de) 1993-10-21
ES2059556T3 (es) 1994-11-16
JPS63316725A (ja) 1988-12-26
IE63453B1 (en) 1995-04-19
DE3720420A1 (de) 1988-12-29
ZA884315B (en) 1989-06-28
AU1775088A (en) 1988-12-22
ATE94391T1 (de) 1993-10-15
IL86731A0 (en) 1988-11-30
IL86731A (en) 1992-11-15
EP0296097B1 (fr) 1993-09-15
AU611160B2 (en) 1991-06-06
IE881804L (en) 1988-12-16
DK327288D0 (da) 1988-06-15
CA1318251C (fr) 1993-05-25

Similar Documents

Publication Publication Date Title
GB2102287B (en) Use of aromatase-inhibitors with antiandrogens for treatment of prostatic hyperplasia.
ES8404845A1 (es) Perfeccionamientos en un aparato de control del estado de un paciente.
DE3850914D1 (de) Gerät für die thermische Therapie von Körpergeweben.
GR880300077T1 (en) Galanthamine or analogues thereof for treating alzheimer's disease
DK196691A (da) Steroid-5-alfa-reduktaseinhibitorer
JPS5413651A (en) House ventilating device
ES2068388T3 (es) Moleculas de receptor de hormona de la glucoproteina.
PH25728A (en) Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type
JPS5431952A (en) Temperature controller
NO883743D0 (no) Framgangsmaate og anordning for aa gi personlig luftbehandling ("air-condition").
JPS52149433A (en) Electronic computer system running system
EP0151385A3 (en) Use of phytosterolglycosides for the treatment of elevated 5(6) alpha-epoxycholesterol levels
AU6461590A (fr)
NZ220242A (en) Regulating fertility in cattle by administering epostane
JPS51141279A (en) Method of improving physical constitution of cattle
JPS51150940A (en) Cashless card and cashless system
JPS5413648A (en) Indoor temperature controller system
ES8602799A1 (es) Un procedimiento para preparar 6-metilsulfoxido-espiro-(croman-4,4'-imidazolidin)-2',5'-diona
JPS51143224A (en) Car driving device for physically handicapped person
JPS53141241A (en) N-p-aminobenzyl-n'-p-aminophenylurea and process for its preparation
Yakiwczuk Analysis of the equivalent tissue air ratio method of photon dose computation
Burchett Race and the AWOL offender: the effect of the defendant's race on the outcome on courts-martial involving absence without leave.
JPS5419069A (en) Hydraulic driving apparatus
EP0278715A3 (fr) Utilisation d'interféron gamma humain pour le traitement du carcinome de cellules basales
AR242981A1 (es) Disposicion para el tratamiento de gas natural.